Literature DB >> 12854135

Expression of NGF family and their receptors in gastric carcinoma: a cDNA microarray study.

Jian-Jun Du1, Ke-Feng Dou, Shu-You Peng, Bing-Zhi Qian, Hua-Sheng Xiao, Feng Liu, Wei-Zhong Wang, Wen-Xian Guan, Zhi-Qing Gao, Ying-Bin Liu, Ze-Guang Han.   

Abstract

AIM: To investigate the expression of NGF family and their receptors in gastric carcinoma and normal gastric mucosa, and to elucidate their effects on gastric carcinoma.
METHODS: RNA of gastric cancer tissues and normal gastric tissues was respectively isolated and mRNA was purified. Probes of both mRNA reverse transcription product cDNAs labeled with alpha-(33)P dATP were respectively hybridized with Atlas Array membrane where NGF and their family genes were spotted on. Hybridized signal images were scanned on phosphor screen with ImageQuant 5.1 software after hybridization. Normalized values on spots were analyzed with ArrayVersion 5.0 software. Differential expression of NGF family and their receptors mRNA was confirmed between hybridized Atlas Array membranes of gastric cancer tissues and normal gastric mucosa, then their effects on gastric carcinoma were investigated.
RESULTS: Hybridization signal images on Atlas Array membrane appeared in a lower level of nonspecific hybridization. Both of NGF family and their receptors Trk family mRNA were expressed in gastric cancer and normal gastric mucosa. But adversely up-regulated expression in other tissues and organs. NGF, BDGF, NT-3, NT-4/5, NT-6 and TrkA, B and C were down-regulated simultaneously in gastric carcinoma in comparison with normal gastric mucosa. Degrees of down-regulation in NGF family were greater than those in their receptors Trk family. Down-regulation of NT-3 and BDGF was the most significant, and TrkC down-regulation level was the lowest in receptors Trk family.
CONCLUSION: Down-regulated expression of NGF family and their receptors Trk family mRNA in gastric cancer is confirmed. NGF family and their receptors Trk family probably play a unique role in gastric cancer cell apoptosis by a novel Ras or Raf signal transduction pathway. Their synchronous effects are closely associated with occurrence and development of gastric carcinoma induced by reduction of signal transduction of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12854135      PMCID: PMC4615477          DOI: 10.3748/wjg.v9.i7.1431

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  44 in total

1.  Neurotransmitters, neuromodulators, and neurotrophin receptors in the gut of pantex, a hybrid sparid fish (Pagrus major x Dentex dentex). Localizations in the enteric nervous and endocrine systems.

Authors:  G Radaelli; C Domeneghini; S Arrighi; L Castaldo; C Lucini; F Mascarello
Journal:  Histol Histopathol       Date:  2001-07       Impact factor: 2.303

2.  DNA arrays for analysis of gene expression.

Authors:  M B Eisen; P O Brown
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 3.  Trk receptor tyrosine kinases: a bridge between cancer and neural development.

Authors:  A Nakagawara
Journal:  Cancer Lett       Date:  2001-08-28       Impact factor: 8.679

4.  Immunohistochemical analysis of TrkA neurotrophin receptor expression in human non-neuronal carcinomas.

Authors:  H Koizumi; M Morita; S Mikami; E Shibayama; T Uchikoshi
Journal:  Pathol Int       Date:  1998-02       Impact factor: 2.534

5.  Identification of silencing of nine genes in human gastric cancers.

Authors:  Atsushi Kaneda; Michio Kaminishi; Kazuyoshi Yanagihara; Takashi Sugimura; Toshikazu Ushijima
Journal:  Cancer Res       Date:  2002-11-15       Impact factor: 12.701

6.  Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.

Authors:  Y Hippo; M Yashiro; M Ishii; H Taniguchi; S Tsutsumi; K Hirakawa; T Kodama; H Aburatani
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

7.  Expression of nerve growth factors in pancreatic neural tissue and pancreatic cancer.

Authors:  M B Schneider; J Standop; A Ulrich; U Wittel; H Friess; A Andrén-Sandberg; P M Pour
Journal:  J Histochem Cytochem       Date:  2001-10       Impact factor: 2.479

8.  Nerve growth factor induces apoptosis in human medulloblastoma cell lines that express TrkA receptors.

Authors:  Y Muragaki; T T Chou; D R Kaplan; J Q Trojanowski; V M Lee
Journal:  J Neurosci       Date:  1997-01-15       Impact factor: 6.167

9.  Detection of differentially expressed genes in lymphomas using cDNA arrays: identification of clusterin as a new diagnostic marker for anaplastic large-cell lymphomas.

Authors:  A Wellmann; C Thieblemont; S Pittaluga; A Sakai; E S Jaffe; P Siebert; M Raffeld
Journal:  Blood       Date:  2000-07-15       Impact factor: 22.113

10.  Gene expression profile differences in high and low metastatic human ovarian cancer cell lines by gene chip.

Authors:  Shenhua Xu; Hanzhou Mou; Guiquan Lü; Chihong Zhu; Zhengyan Yang; Yongliang Gao; Hongkun Lou; Xianglin Liu; Yong Cheng; Wen Yang
Journal:  Chin Med J (Engl)       Date:  2002-01       Impact factor: 2.628

View more
  3 in total

1.  Neurotrophin-3 production promotes human neuroblastoma cell survival by inhibiting TrkC-induced apoptosis.

Authors:  Jimena Bouzas-Rodriguez; Jorge Ruben Cabrera; Céline Delloye-Bourgeois; Gabriel Ichim; Jean-Guy Delcros; Marie-Anne Raquin; Raphaël Rousseau; Valérie Combaret; Jean Bénard; Servane Tauszig-Delamasure; Patrick Mehlen
Journal:  J Clin Invest       Date:  2010-02-15       Impact factor: 14.808

2.  Gastric cancer biomarkers; A systems biology approach.

Authors:  Mohammad Saberi Anvar; Zarrin Minuchehr; Mohsen Shahlaei; Samira Kheitan
Journal:  Biochem Biophys Rep       Date:  2018-02-12

3.  Individual and co-expression patterns of nerve growth factor and heme oxygenase-1 predict shorter survival of gastric carcinoma patients.

Authors:  Sang Jae Noh; Kyoung Min Kim; Kyu Yun Jang
Journal:  Diagn Pathol       Date:  2017-07-05       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.